Dietary fat has been linked to several diseases including insulin resistance, obesity, hypertension, atherosclerosis and certain types of cancers. Both the quantity and type of dietary fat contribute to the development and progression of these diseases. Recent experimental evidence indicates that the effect of fat is directed at the cellular level and involves both rapid and adaptive processes. Our studies have focused on the well-known suppression of hepatic lipogenesis by dietary polyunsaturated fatty acids (PUFA). PUFA effects on hepatic lipogenesis contribute to the decline in very low density lipoprotein (VLDL) output and a suppression of serum triglyceride (as VLDL) levels. Our studies have shown that PUFA suppress hepatic de novo lipogenesis by inhibiting the transcription of genes encoding key enzymes involved in both lipogenesis and glycolysis. Using two models, i.e. the hepatic S14 gene (lipogenic gene model) and L-pyruvate kinase (glycolytic gene model), we have shown that the molecular targets for PUFA action are cis- regulatory elements (PUFA-RE) located within the proximal promoters of these genes. PUFA-RE serve as targets for PUFA-regulated factors (PUFA- RF) that interfere with the hormonal [triiodothyronine (T3) and insulin] activation of gene transcription, i.e. dominant negative control. The following studies are proposed to characterize further the molecular basis of PUFA action: 1) to use a transfection approach of primal hepatocytes to define the DNA sequences that are sufficient and necessary for PUFA-mediated suppression of the S14 gene; 2) to use a transfection approach to understand how PUFA-RE function within the context of the proximal promoter elements and upstream hormone-regulated enhancers; and 3) to isolate and characterize PUFA-RF to define further the mechanism of PUFA-mediated interference of hormone regulation of gene transcription. The information gained from these studies will be of significant biomedical importance because of the elucidation of the molecular mechanisms of PUFA-mediated control of lipogenic gene transcription. These studies may be useful in the development of novel hypolipemic and anti-obesity agents. Finally, we will obtain new insight into PUFA effects on human health and development and how fatty acid effects on hormonal regulation may contribute to the progression of such diseases as obesity, insulin resistance, cardiovascular disease and carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043220-08
Application #
2749468
Study Section
Nutrition Study Section (NTN)
Program Officer
May, Michael K
Project Start
1991-08-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Michigan State University
Department
Physiology
Type
Schools of Arts and Sciences
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Jump, Donald B; Depner, Christopher M; Tripathy, Sasmita et al. (2016) Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice. Proc Nutr Soc 75:1-9
Lytle, Kelli A; Depner, Christopher M; Wong, Carmen P et al. (2015) Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGF?-Smad3 pathway. J Lipid Res 56:1936-46
Tripathy, Sasmita; Lytle, Kelli A; Stevens, Robert D et al. (2014) Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice. J Lipid Res 55:1448-64
Tripathy, Sasmita; Jump, Donald B (2013) Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. J Lipid Res 54:71-84
Depner, Christopher M; Torres-Gonzalez, Moises; Tripathy, Sasmita et al. (2012) Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice. J Nutr 142:1495-503
Lebold, Katie M; Jump, Donald B; Miller, Galen W et al. (2011) Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio). J Nutr 141:2113-8
Jump, Donald B (2011) Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 14:115-20
Jump, Donald B; Torres-Gonzalez, Moises; Olson, L Karl (2011) Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol 81:649-60
Tikhonenko, Maria; Lydic, Todd A; Wang, Yun et al. (2010) Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59:219-27
Tripathy, Sasmita; Torres-Gonzalez, Moises; Jump, Donald B (2010) Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice. J Lipid Res 51:2642-54

Showing the most recent 10 out of 53 publications